Philmans Pharm,, The German Patient Roundtable

Est. 1977

19 January 2017 – a historic day in Germany!


Today the agreed German Bundestag unanimously for a supply of critically ill patients with cannabis drugs at the expense of the statutory health insurance.

The law allows physicians to prescribe cannabis flowers as other drugs. Patients receive in certain cases a cost reimbursement for cannabis drugs by the health insurance companies. The law creates the basis for a licensed cultivation of cannabis as medicine in Germany.

The application of the left group, to ensure access to cannabis comprising as medicine has been rejected.

You will find more on the topic soon at


Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA + GERMANY Skype: philip.j.cenedella eMail: LinkedIN:

Comments are closed.